Mimedx (MDXG) Payables (2010 - 2026)

Mimedx has disclosed Payables across 17 years of filings, most recently posting $11.5 million for Q1 2026.

• Payables for Q1 2026 came in at $11.5 million, up 29.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.5 million (up 29.27% YoY), and the FY2025 annual result was $14.5 million, up 96.09% from the prior year.
• Payables came in at $11.5 million for Q1 2026 at Mimedx, down from $14.5 million in the prior quarter.
• In the past five years, Payables ranged from a high of $14.5 million in Q4 2025 to a low of $6.9 million in Q3 2024.
• The 5-year median for Payables is $8.5 million (2025), against an average of $9.1 million.
• Across the five-year window, Payables fell 24.49% in 2024 and surged 96.09% in 2025, its largest moves.
• Mimedx's Payables stood at $8.5 million in 2022, then climbed by 7.03% to $9.0 million in 2023, then fell by 18.11% to $7.4 million in 2024, then soared by 96.09% to $14.5 million in 2025, then decreased by 21.09% to $11.5 million in 2026.
• The last three Payables figures came in at $11.5 million (Q1 2026), $14.5 million (Q4 2025), and $11.4 million (Q3 2025), per Business Quant data.